SILICON LABORATORIES INC (SLAB) Fundamental Analysis & Valuation

NASDAQ:SLAB • US8269191024

Current stock price

209.13 USD
+1.42 (+0.68%)
At close:
209.13 USD
0 (0%)
After Hours:

This SLAB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. SLAB Profitability Analysis

1.1 Basic Checks

  • In the past year SLAB was profitable.
  • In the past year SLAB had a positive cash flow from operations.
  • In multiple years SLAB reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SLAB reported negative operating cash flow in multiple years.
SLAB Yearly Net Income VS EBIT VS OCF VS FCFSLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

1.2 Ratios

  • SLAB has a worse Return On Assets (-5.11%) than 64.35% of its industry peers.
  • Looking at the Return On Equity, with a value of -5.93%, SLAB is doing worse than 61.74% of the companies in the same industry.
Industry RankSector Rank
ROA -5.11%
ROE -5.93%
ROIC N/A
ROA(3y)-7.71%
ROA(5y)10.53%
ROE(3y)-8.82%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
SLAB Yearly ROA, ROE, ROICSLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

1.3 Margins

  • SLAB's Gross Margin of 58.23% is amongst the best of the industry. SLAB outperforms 81.74% of its industry peers.
  • In the last couple of years the Gross Margin of SLAB has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for SLAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.46%
GM growth 5Y0.18%
SLAB Yearly Profit, Operating, Gross MarginsSLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

8

2. SLAB Health Analysis

2.1 Basic Checks

  • SLAB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SLAB has been increased compared to 1 year ago.
  • SLAB has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for SLAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SLAB Yearly Shares OutstandingSLAB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
SLAB Yearly Total Debt VS Total AssetsSLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 25.62 indicates that SLAB is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 25.62, SLAB belongs to the top of the industry, outperforming 87.83% of the companies in the same industry.
  • SLAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.62
ROIC/WACCN/A
WACC11.6%
SLAB Yearly LT Debt VS Equity VS FCFSLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • SLAB has a Current Ratio of 4.69. This indicates that SLAB is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.69, SLAB is in the better half of the industry, outperforming 68.70% of the companies in the same industry.
  • A Quick Ratio of 4.02 indicates that SLAB has no problem at all paying its short term obligations.
  • SLAB has a Quick ratio of 4.02. This is in the better half of the industry: SLAB outperforms 69.57% of its industry peers.
Industry RankSector Rank
Current Ratio 4.69
Quick Ratio 4.02
SLAB Yearly Current Assets VS Current LiabilitesSLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

8

3. SLAB Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 152.91% over the past year.
  • The earnings per share for SLAB have been decreasing by -21.23% on average. This is quite bad
  • Looking at the last year, SLAB shows a very strong growth in Revenue. The Revenue has grown by 34.29%.
  • Measured over the past years, SLAB shows a quite strong growth in Revenue. The Revenue has been growing by 8.96% on average per year.
EPS 1Y (TTM)152.91%
EPS 3Y-42.31%
EPS 5Y-21.23%
EPS Q2Q%609.09%
Revenue 1Y (TTM)34.29%
Revenue growth 3Y-8.49%
Revenue growth 5Y8.96%
Sales Q2Q%25.24%

3.2 Future

  • Based on estimates for the next years, SLAB will show a very strong growth in Earnings Per Share. The EPS will grow by 70.47% on average per year.
  • SLAB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.81% yearly.
EPS Next Y204.7%
EPS Next 2Y115.53%
EPS Next 3Y70.47%
EPS Next 5YN/A
Revenue Next Year18.24%
Revenue Next 2Y17.44%
Revenue Next 3Y15.81%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SLAB Yearly Revenue VS EstimatesSLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
SLAB Yearly EPS VS EstimatesSLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

2

4. SLAB Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 229.81, SLAB can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Earnings ratio as SLAB.
  • Compared to an average S&P500 Price/Earnings ratio of 26.17, SLAB is valued quite expensively.
  • A Price/Forward Earnings ratio of 75.42 indicates a quite expensive valuation of SLAB.
  • Based on the Price/Forward Earnings ratio, SLAB is valued a bit more expensive than the industry average as 60.87% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of SLAB to the average of the S&P500 Index (23.05), we can say SLAB is valued expensively.
Industry RankSector Rank
PE 229.81
Fwd PE 75.42
SLAB Price Earnings VS Forward Price EarningsSLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

  • SLAB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 104.81
EV/EBITDA N/A
SLAB Per share dataSLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as SLAB's earnings are expected to grow with 70.47% in the coming years.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y115.53%
EPS Next 3Y70.47%

0

5. SLAB Dividend Analysis

5.1 Amount

  • SLAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SLAB Fundamentals: All Metrics, Ratios and Statistics

SILICON LABORATORIES INC

NASDAQ:SLAB (4/2/2026, 8:00:02 PM)

After market: 209.13 0 (0%)

209.13

+1.42 (+0.68%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)04-29
Inst Owners102.77%
Inst Owner Change0%
Ins Owners2.03%
Ins Owner Change1.81%
Market Cap6.90B
Revenue(TTM)784.76M
Net Income(TTM)-64.91M
Analysts68.89
Price Target219.88 (5.14%)
Short Float %4.01%
Short Ratio1.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.16%
Min EPS beat(2)0.17%
Max EPS beat(2)2.15%
EPS beat(4)4
Avg EPS beat(4)7.94%
Min EPS beat(4)0.17%
Max EPS beat(4)16.59%
EPS beat(8)7
Avg EPS beat(8)11.43%
EPS beat(12)8
Avg EPS beat(12)8.98%
EPS beat(16)12
Avg EPS beat(16)14.53%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-1.66%
Revenue beat(4)0
Avg Revenue beat(4)-1.74%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)-1.66%
Revenue beat(8)1
Avg Revenue beat(8)-1.15%
Revenue beat(12)1
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.59%
PT rev (1m)0%
PT rev (3m)42.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.8%
EPS NY rev (1m)0%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.7%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.56%
Valuation
Industry RankSector Rank
PE 229.81
Fwd PE 75.42
P/S 8.79
P/FCF 104.81
P/OCF 72.04
P/B 6.3
P/tB 9.92
EV/EBITDA N/A
EPS(TTM)0.91
EY0.44%
EPS(NY)2.77
Fwd EY1.33%
FCF(TTM)2
FCFY0.95%
OCF(TTM)2.9
OCFY1.39%
SpS23.8
BVpS33.19
TBVpS21.08
PEG (NY)1.12
PEG (5Y)N/A
Graham Number26.07
Profitability
Industry RankSector Rank
ROA -5.11%
ROE -5.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.23%
FCFM 8.38%
ROA(3y)-7.71%
ROA(5y)10.53%
ROE(3y)-8.82%
ROE(5y)15.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.46%
GM growth 5Y0.18%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 78.57%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.69
Quick Ratio 4.02
Altman-Z 25.62
F-Score6
WACC11.6%
ROIC/WACCN/A
Cap/Depr(3y)48.79%
Cap/Depr(5y)47.77%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)152.91%
EPS 3Y-42.31%
EPS 5Y-21.23%
EPS Q2Q%609.09%
EPS Next Y204.7%
EPS Next 2Y115.53%
EPS Next 3Y70.47%
EPS Next 5YN/A
Revenue 1Y (TTM)34.29%
Revenue growth 3Y-8.49%
Revenue growth 5Y8.96%
Sales Q2Q%25.24%
Revenue Next Year18.24%
Revenue Next 2Y17.44%
Revenue Next 3Y15.81%
Revenue Next 5YN/A
EBIT growth 1Y57.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year452.96%
EBIT Next 3Y99.57%
EBIT Next 5YN/A
FCF growth 1Y356.4%
FCF growth 3Y13.24%
FCF growth 5Y-10.97%
OCF growth 1Y788.05%
OCF growth 3Y10.05%
OCF growth 5Y-6.74%

SILICON LABORATORIES INC / SLAB Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SILICON LABORATORIES INC (SLAB) stock?

ChartMill assigns a fundamental rating of 5 / 10 to SLAB.


What is the valuation status for SLAB stock?

ChartMill assigns a valuation rating of 2 / 10 to SILICON LABORATORIES INC (SLAB). This can be considered as Overvalued.


Can you provide the profitability details for SILICON LABORATORIES INC?

SILICON LABORATORIES INC (SLAB) has a profitability rating of 2 / 10.


What is the earnings growth outlook for SILICON LABORATORIES INC?

The Earnings per Share (EPS) of SILICON LABORATORIES INC (SLAB) is expected to grow by 204.7% in the next year.